← FDA Drug Approvals (Drugs@FDA)

BLEPH-10

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALLERGAN · Approved 1975-01-07

Drug application

FDA Application #

ANDA084015

Application type

Abbreviated New Drug Application (Generic)

Brand name

BLEPH-10

Generic name

Sulfacetamide Sodium

Active ingredients

SULFACETAMIDE SODIUM

Dosage form

OINTMENT

Route

OPHTHALMIC

Marketing status

Discontinued

Sponsor

ALLERGAN

First approval

1975-01-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown